HIV/AIDS - Nov 30, 2018 Edition

Can't see this email? View it online

	November 30, 2018
	HIV/AIDS
	The latest HIV/AIDS news from News Medical

Liver immune cells contain inert HIV and are unlikely to reproduce infection, study reveals

In a proof-of-principle study, researchers at Johns Hopkins revealed that certain immune system cells found in the human liver, called liver macrophages, contain only inert HIV and aren't likely to reproduce infection on their own in HIV-infected people on long-term antiretroviral therapy.

			Study reveals direct link between stigma and cognitive performance in people with HIV A new study has drawn a direct link between the amount of stigma men with HIV report experiencing and their scores on cognitive tests, measuring abilities such as memory and attention.

			HIV-2 is more pathogenic than previously demonstrated, finds study A study published in The Lancet HIV shows that HIV-2 is more pathogenic than previously demonstrated. The new findings indicate that early treatment should be applied to all patients with HIV, not only to those with HIV-1.

	Scripps Research scientists reveal potential new approach to design HIV vaccines A new candidate HIV vaccine from Scripps Research surmounts technical hurdles that stymied previous vaccine efforts, and stimulates a powerful anti-HIV antibody response in animal tests.

	Is Europe on track to end AIDS by 2020? From diagnosis of HIV to successful viral suppression: in a rapid communication published in Eurosurveillance today, ECDC and co-authors from Public Health England and The National AIDS Trust summarise the progress towards HIV elimination in 52 countries in Europe and Central Asia.

	Mechanisms that govern HIV latency differ in the gut and blood, finds study Mechanisms that govern HIV transcription and latency differ in the gut and blood, according to a study published November 15 in the open-access journal PLOS Pathogens by Steven Yukl of San Francisco Veterans Affairs Medical Center and the University of California, San Francisco, and colleagues.

	Innate Resistance to HIV through Natural Killer Cells Natural killer (NK) cells are large granular lymphocytes. They possess natural cytotoxicity against tumor cells and virus-infected cells, and they produce cytokines.

	HIV targets achieved by United Kingdom, says report The Joint United Nations Programme on HIV/Aids (UNAids) target for 2020 is 90-90-90 which means 90 percent people with HIV would be diagnosed, 90 percent of those diagnosed would receive anti-HIV or anti-retroviral treatment and 90 percent of those treated with antiretroviral drugs would achieve suppression of their viral load so that they cannot transmit the infection to others.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions